Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Hotung Investment Holdings Limited is a premier venture capital and fund management group primarily based in Taiwan and listed on the Singapore Exchange. Established in 1987, the company has over 35 years of experience identifying innovation and value across global markets, including Taiwan, China, and Silicon Valley. While the firm operates as a financial investment entity, it maintains a significant focus on the Life Sciences, Biotechnology, and Healthcare sectors within its diverse investment portfolio. Hotung manages both its own venture capital funds and third-party capital, providing consultancy and advisory services through its fund management segment. Notable healthcare-related successes in its portfolio include investments in ACT Genomics and the formerly NASDAQ-listed Anadys Pharmaceuticals. The group has overseen more than 200 successful IPOs and acquisitions of its portfolio companies on major international exchanges.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Hotung Investment Holdings.